AzTrials
AzTrials

Shoulder PainNCT00884065

Effectiveness of Diacutaneous Fibrolysis in Painful Shoulder

A study testing Diacutaneous Fibrolysis in people with Shoulder Pain, run by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

While Diacutaneous fibrolysis (DF) has achieved promising results empirically, its effectiveness has not been tested in clinical trials. The investigators hypothesized that the use of DF in patients suffering from painful shoulder would increase the active mobility and reduce the pain during movement. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Shoulder Pain
What is being tested?
Diacutaneous Fibrolysis
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
50 participants
Where
1 siteSpain
Study dates
Jun 2007to Jan 2008
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • over 18 years of age
  • being referred for treatment of painful shoulder (except for adhesive capsulitis)
  • not having been previously treated with DF

Who cannot join

  • Damaged skin and/or cutaneous lesions in the shoulder area
  • History of shoulder surgery
  • Vascular abnormalities
  • Platelet antiaggregant therapy
  • Acute inflammatory condition of the shoulder (<1 week)
  • Patients with a pending litigation or court claim

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Catalan Institute of Health - Servei de Rhb Sant Ildefons

    Cornellà de Llobregat, Barcelona, 08940

Other trials in Spain

About this study

Official title: Effectiveness of Diacutaneous Fibrolysis on Pain and Mobility in Patients Suffering From Painful Shoulder. A Randomized Pilot Study.

While Diacutaneous fibrolysis (DF) has achieved promising results empirically, its effectiveness has not been tested in clinical trials. The investigators hypothesized that the use of DF in patients suffering from painful shoulder would increase the active mobility and reduce the pain during movement. To test the hypothesis a double blind (patient and investigator) randomized clinical trial was carried out in two public Primary Health Care Centres. Fifty patients were randomly allocated to two groups: the intervention group, who received a real DF session, and the control group, who received a placebo DF session.

Read the detailed description

Background and objectives:

Diacutaneous fibrolysis (DF) is a manual technique to treat the mechanical pain of the musculoskeletal system. While this technique has achieved promising results empirically, its effectiveness has not been tested in clinical trials. We aimed at evaluating the effectiveness of a single session of DF on pain and mobility in patients suffering from painful shoulder.

Subjects and methods:

This clinical trial took place in two public Primary Health Care Centres. Fifty patients were randomly allocated to two groups: the intervention group, who received a real DF session, and the control group, who received a placebo DF session. The degree of active mobility (flexion, abduction, extension, external and internal rotation), the pain in the hand behind back position and the participant's perception of the technique in terms of comfort and results obtained were measured.

Conditions
Shoulder Pain
Being tested
Diacutaneous Fibrolysis, Diacutaneous Fibrolysis (placebo)
Keywords
Physiotherapy, Manual therapy, Painful Shoulder, Diacutaneous Fibrolysis
Medical subject headings
Shoulder Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Diacutaneous FibrolysisOther

    Also called Manual therapy

    The implementation of the technique consists of three consecutive stages: The first stage involves manual palpation, which is carried out by the hand that is not holding the hook, with the objective to find the area to be treated; the second, or instrumental palpation stage, is carried out by introducing the spatula of the hook together with the index finger of the palpatory hand to locate with precision the adherent connective fibers or fibrous corpuscles; the third, or fibrolysis stage, is the actual treatment. Here, a brief supplementary traction is carried out with the hook.

  • Diacutaneous Fibrolysis (placebo)Other

    Also called Manual therapy

    The placebo was designed for this study and the stages of manual and instrumental palpation occur strictly at a superficial level. In the third stage, instead of fibrolysis a pinch of skin is hold with the thumb of the palpatory hand and the tip of the spatula, so that the patient feels the hook distinctly but without any action taking place on the deep tissular planes.

Study groups in NCT00884065
Study groupRoleWhat they receive
Intervention GroupExperimentalThe intervention group was treated with a single session of DF following the procedure as described by the authors.
Receives: Other: Diacutaneous Fibrolysis
Control GroupPlacebo comparatorThe control group was treated with a single placebo session of DF.
Receives: Other: Diacutaneous Fibrolysis (placebo)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Active Flexion Movement After Intervention Minus Baseline

    A universal double armed goniometer was used to measure change in active flexión movement in the sagital plane with the elbow fully extended and the forearm in indifferent pronosupination (thumb forward)

    Measured: Baseline and the same day (just after intervention)

  2. Change in Active Abduction Movement After Intervention Minus Baseline

    A universal double armed goniometer was used to measure change in active abduction movement in the scapular plane with the elbow in extension and the forearm in supination

    Measured: Baseline and the same day (just after intervention)

  3. Change in Active extensión Movement After Intervention Minus Baseline

    A universal double armed goniometer was used to measure change in active extensión movement in the sagital plane with the elbow fully extended and the forearm in indifferent pronosupination (thumb forward)

    Measured: Baseline and the same day (just after intervention)

  4. Change in Active External Rotation After Intervention Minus Baseline

    A universal double armed goniometer was used to measure change in active external rotation measured in the neutral position of the shoulder (arm pinned to the trunk), elbow flexed to 90º and the forearm in indifferent pronosupination (thumb forward)

    Measured: Baseline and the same day (just after intervention)

  5. Change in Active Internal Rotation After Intervention Minus Baseline

    Change in active internal rotation was measured with the hand behind back test. The position achieved by the tip of the thumb was marked and with a flexible metric tape (always the same) the distance in centimetres between this mark and the inferior tip of the spinous process of C7 was measured; the shorter the distance, the better the mobility

    Measured: Baseline and the same day (just after intervention)

Secondary outcomes (1)
  1. Change in Pain in the Hand Behind Back Position After Intervention Minus Baseline

    An unmarked Visual Analogue Scale from 0 (no pain) to 100 (worst pain) millimeters was used. At baseline, participants registered the pain perceived in the position used to measure the internal rotation. After intervention, they registered the pain with the hand placed in the same position taking as a reference the mark in the first evaluation.

    Measured: Baseline and the same day (just after intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Apr 2009 (estimated)
  2. Study startJun 2007
  3. Primary completionJan 2008
  4. Study completionJan 2008

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00884065
Sponsor's protocol ID
Idiap08/187
Status last verified
Mar 2015
First submitted
9 Feb 2009
Last updated
23 Mar 2015

Publications

  • Barra ME, Lopez C, Fernandez G, Murillo E, Villar E, Raya L. The immediate effects of diacutaneous fibrolysis on pain and mobility in patients suffering from painful shoulder: a randomized placebo-controlled pilot study. Clin Rehabil. 2011 Apr;25(4):339-48. doi: 10.1177/0269215510385480. Epub 2010 Nov 15.

    PubMed 21078700

Questions about this trial

What is this clinical trial studying?

A study testing Diacutaneous Fibrolysis in people with Shoulder Pain, run by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Mar 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 20 Apr 2009). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Active Flexion Movement After Intervention Minus Baseline (time frame: Baseline and the same day (just after intervention)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00884065, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Mar 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in